Join the Labora Collective
Full access to physician-led journalism, intelligence, and tools for women's health — designed for the people who live it and the people who treat it.
Create your free account →
Already a member? Sign in → · Have an access code? Redeem it →
Membership
Choose the level that fits you
Diosa Circle
For everyone
Free / forever
No credit card required
The Signal — the week's new evidence, free
Selected free articles & essays
Monthly Labora Digest
Event invitations & community previews
Create free account
Includes The Signal newsletter, free — delivered the moment your account is live.
Diosa Essentials
Patients · Doulas · Students
$30 $15 /mo
Billed monthly or annually · Cancel anytime
Everything in Diosa Circle
Full journal access — all three publications
Complete archive of published content
Community membership & discussion
Subscribe — $15 / month Pay annually — $150 / year
Coming soon
Diosa Insiders
Providers · Researchers · Institutions
$27.50 /mo
Professional intelligence tier
Everything in Essentials
Intelligence Reports & Special Reports
Professional resources & licensing rights
Packs & Playbooks access
Viva Voce — premium voice product
Coming soon
Coming soon
Labora Luminaries
Co-Investment · Leadership circle
$150 /mo
$1,500 / year
Everything in Diosa Insiders
Strategy sessions with Dr. Connor
Governance & advisory participation
Annual Labora Summit invitation
Co-investment in women's health infrastructure
Coming soon
August 1, 2026
What's inside the Labora Collective
The Labora Collective publishes three journals (Women's Health, In Her Name, The Blueprint), two newsletters (The Signal OB, The Signal GYN-RJ), a long-form interview series (Viva Voce), a two-stream intelligence system (Research + Clinical), and a guided care bundle library (Packs).
Every article uses the 3-Layer Source Transparency system — visual evidence, contextual text, and editorial analysis are separated so you can verify claims and draw your own conclusions.
Membership funds physician-led, independent journalism for women's health. No pharma sponsors. No hospital system editorial control. No audience-shaped conclusions.